生物工程微针和纳米医学作为组织再生的治疗平台
Yi-An Mao1,2, Shihui Xu1,2, Xiaozhou Shi1,2
1Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) and School of Life Science, Shanghai University, Nantong, 226011, China.
Journal of nanobiotechnology
|August 20, 2025
概括
微针 (MNs) 和纳米医学为具有挑战性的组织再生和癌症治疗提供了创新的局部治疗方法. 它们的整合有望提高患者的治疗效果,
科学领域:
- 生物医学工程
- 复原医学
- 纳米技术
背景情况:
- 由于复杂的愈合失调, 组织再生面临慢性伤口,器官损伤和退行性疾病的挑战.
- 传统疗法如移植和全身药物在组织修复方面的特异性,有效性和安全性都有局限性.
- 需要新兴技术来克服再生医学的这些局限性.
研究的目的:
- 审查微针和纳米医学在组织再生中的挑战和治疗策略.
- 探索它们在癌症相关治疗中的应用.
- 突出创新和将MN与纳米医学结合用于精确的再生疗法的潜力.
主要方法:
- 关于微针设计和纳米医学在组织再生中的应用的最新文献.
- 对生物工程MN与纳米载体的功能多样性和整合进行分析.
- 探索特定组织再生和癌症治疗背景下的案例研究.
主要成果:
- 微针 (MNs) 和纳米医学可实现局部,可控和最小侵入性干预以进行组织再生.
- 生物工程MN表现出多种功能,增强药物输送和治疗效果.
- 将MN与纳米医学结合起来, 证明了精确的再生疗法的变革潜力.
结论:
- 微针和纳米医学的整合为先进的组织再生和癌症治疗提供了一个有前途的前沿.
- 未来的前景指向智能,个性化的再生疗法,
- 这些创新为对抗传统方法的复杂疾病提供了新的希望.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314


